Adverse drug reactions in special populations - the elderly.
about
Potential drug-drug interactions among elderly patients admitted to medical ward of Ayder Referral Hospital, Northern Ethiopia: a cross sectional study.Decreasing the load? Is a Multidisciplinary Multistep Medication Review in older people an effective intervention to reduce a patient's Drug Burden Index? Protocol of a randomised controlled trialClinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice.Delirium in the geriatric unit: proton-pump inhibitors and other risk factors.Prevalence and impact of Clostridium difficile infection in elderly residents of long-term care facilities, 2011: A nationwide studyCross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh.Hospitalizations Due to Adverse Drug Events in the Elderly-A Retrospective Register StudyPotentially Inappropriate Medication in Community-Dwelling Primary Care Patients who were Screened Positive for Dementia.Deprescribing medicines in the acute setting to reduce the risk of fallsEvaluation of Potentially Drug-Related Patient-Reported Common Symptoms Assessed During Clinical Medication Reviews: A Cross-Sectional Observational Study.Hydration status, drug interactions, and determinants in a Spanish elderly population: a pilot study.Evidence for strategies that improve recruitment and retention of adults aged 65 years and over in randomised trials and observational studies: a systematic review.Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission.Medication errors in home care: a qualitative focus group study.Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial.Blood pressure and all-cause mortality: a prospective study of nursing home residents.Impact of Ageing on Serum Concentrations of Risperidone and Its Active Metabolite in Patients with Known CYP2D6 Genotype.Perspectives on the risks for older adults living independently.An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia.Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function.Early rehospitalizations of frail elderly patients - the role of medications: a clinical, prospective, observational trialAdverse Drug reactions in an Ageing PopulaTion (ADAPT) study protocol: a cross-sectional and prospective cohort study of hospital admissions related to adverse drug reactions in older patients.Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives.Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know?High prevalence of prescription of psychotropic drugs for older patients in a general hospital.Preventable ADRs leading to hospitalization - results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients.Medication governance: preventing errors and promoting patient safety.Withdrawal of antihypertensive therapy in people with dementia: feasibility study.Systolic blood pressure decline in very old individuals is explained by deteriorating health: Longitudinal changes from Umeå85+/GERDA.Factors associated with adverse drug reactions in older inpatients in teaching hospital.The epidemiology of polypharmacy in older adults: register-based prospective cohort study.Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study.
P2860
Q36120277-22CAF247-B18B-4CA0-8C12-0FD828BB92BDQ36406116-2C6B23BA-4FB3-4040-BA71-3E779E201FD5Q36410106-6FED4E1C-C8D5-48F1-AC2B-957478B0CA69Q36786953-552CEAB5-C3F0-4E95-A690-07826FCBA462Q37164910-23DAF323-1A29-409C-9BC9-6EC56ADA1349Q37177754-1F92D59F-A532-485A-B6F0-98A34FBF0C37Q37312143-C3F6EBC5-F7D2-4B69-BF80-443141E61031Q37489285-B5EE1DEF-5848-4A4C-826B-15CB9FEEEF50Q37617040-366D0395-705A-48C4-8DDF-5A7894D5E794Q37742262-7445CB97-CFD9-4DE0-BA95-86A00A90613CQ38629338-AA39258A-6DAD-4E1D-A268-CDBC9C9D0A75Q38798141-7B4E7382-D0DD-470D-B108-2CC2698F92B2Q38865456-343B3FF3-4DD6-4615-B8CB-B9664F644DCAQ38972417-12EB12E0-AA3C-4718-AA11-F77DEB945EF1Q38984048-55EAF993-B73D-4716-BAA3-BE9C11533106Q39395073-B73A638D-C32B-4C46-9CDE-1193C78214F0Q39517847-9E345295-9DFD-4A94-8342-F203289C8562Q39795136-1366F200-652F-4884-8457-7EA093898647Q40132030-C8886E3D-6AAE-4568-B028-E1FC9A2210E2Q40185150-1CDF02DF-9690-4B34-8B7C-F7F5CD5EA251Q40392507-CB640AF9-E70D-442D-BAC1-66845C7FF221Q41522418-32667A14-4392-4D7D-ADFB-CCA25AC74FBAQ47101791-1BCEA68D-53A5-42C6-9267-1D5412095712Q47213588-827CDCCC-D3C0-427F-9474-E4FFE87D396FQ47450129-318935E4-EA17-4287-BD77-E802ACDBB3C0Q47569569-FB360F99-67B6-43B7-8950-547A8708662BQ47573647-512C15FA-E160-49C3-B837-3C8CBCB569C3Q47993272-943E2ABF-8624-42C9-B152-D311953A31F1Q48231243-C770C251-07A5-4F4F-ACA8-EBB8FB4CE322Q49285382-D1F298B3-A16F-497D-A428-EED66B129F61Q50678058-CFA87E19-A3D9-49FB-96AE-A0134214C2D8Q51761139-9D101CB8-71D1-41DB-B152-908140166311Q55121600-6922FF86-99BE-4656-AF68-7C69925AB761
P2860
Adverse drug reactions in special populations - the elderly.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Adverse drug reactions in special populations - the elderly.
@ast
Adverse drug reactions in special populations - the elderly.
@en
type
label
Adverse drug reactions in special populations - the elderly.
@ast
Adverse drug reactions in special populations - the elderly.
@en
prefLabel
Adverse drug reactions in special populations - the elderly.
@ast
Adverse drug reactions in special populations - the elderly.
@en
P2860
P356
P1476
Adverse drug reactions in special populations - the elderly.
@en
P2093
E A Davies
M S O'Mahony
P2860
P304
P356
10.1111/BCP.12596
P407
P577
2015-01-24T00:00:00Z